IgA Nephropathy: Prognosis and Current Therapies in 2026
IgA Nephropathy is the most common cause of primary kidney inflammation. New 2026 guidelines recommend early combination therapy to reduce proteinuria below 0.5 g/day and prevent kidney failure. Nefecon, sparsentan, and lifestyle changes are now key.
Read More
